This site is intended for Healthcare Professionals only.

Apixaban witnessed £280m rise in its cost since 2021/22

Date:

Share post:

Atorvastatin, a medicine to treat high blood cholesterol, is the most dispensed drug with 59 million items in England in 2022/23, revealed the NHS Business Services Authority (NHSBSA) on Thursday (8 June).

While Apixaban (an anticoagulant) was the drug with the highest costs of £430 million. Apixaban 5mg tablets had the largest increase in cost between 2021/22 and 2022/23 in England, with an increase of £280 million.

NHSBSA’s annual statistics report ‘Prescription Cost Analysis-England 2022/23’ published also has revealed an eight per cent rise in the prescription items that were dispensed in the community in England.

The report highlighted that in 2022/23, 1.18 billion prescription items were dispensed at a cost of £10.4 billion in the community in England, witnessing an increase of eight per cent  from £9.69 billion in 2021/22.

Compared to 2014/15, the cost has increased by 17 per cent or £1.48 billion. This marks the fourth year in a row where the cost of items dispensed has increased, after seeing a decrease in the previous three years from 2015/16 to 2018/19.

The report also showed the number of drugs and medical devices (such as blood glucose monitors) dispensed in the community in England increased by 3 per cent to 1.18 billion, from 1.14 billion in 2021/22. Compared to 2014/15, this number has increased by 10 per cent.

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue December 2023

Related articles

Pfizer says its RSV shot is protective through a second year

Pfizer on Thursday said a single dose of its new respiratory syncytial virus (RSV) vaccine Abrysvo maintained its...

Novavax sees 2024 sales flat to lower, aims to pick up Covid vaccine market share

Covid-19 vaccine maker Novavax on Wednesday said it expects revenue this year to be flat or lower as...

Drugmaker Sandoz to pay $265m to settle US pricing case

Swiss generic drugmaker Sandoz said on Thursday that it would pay $265 million (£209m) to settle a pricing...

Pharmacists critical in helping people to practice self-care with confidence: survey

People are opting to visit pharmacists for self-care and are conscious of the positive impact it can have...